Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.31 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15782452 | 0.89 | L3MBTL1 (0.34) | L3MBTL1EPHX1TSHR | |
| SCHEMBL84880 | 0.88 | — | — | |
| SCHEMBL17198005 | 0.88 | — | — | |
| SCHEMBL25152759 | 0.88 | — | — | |
| SCHEMBL13075927 | 0.88 | — | — | |
| SCHEMBL12423 | 0.88 | — | — | |
| SCHEMBL1908789 | 0.88 | — | — | |
| SCHEMBL6127993 | 0.88 | — | — | |
| Hydrochloric Acid SCHEMBL28367771 | 0.85 | EPHX1 (0.39) | KDM1AMAOBEPHX1 | |
| Hydrochloric Acid SCHEMBL5207742 | 0.85 | EPHX1 (0.39) | KDM1AMAOBEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230031665-A1 | COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | RENIBUS THERAPEUTICS, INC. | 2023-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230031665-A1 | COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | SLC10A2, SLC10A1, GLS | KDM1A 3600/4885MAOB 1097/4885L3MBTL1 1552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.